Frank Torti - Jan 10, 2022 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Director
Signature
/s/ Eva Renee Barnett, attorney-in-fact for Frank Torti
Stock symbol
IMVT
Transactions as of
Jan 10, 2022
Transactions value $
$0
Form type
4
Date filed
1/12/2022, 04:13 PM
Previous filing
Jun 7, 2021
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMVT Common Stock Award $0 +100K +210.35% $0.00 148K Jan 10, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +329K +146.27% $0.00 555K Jan 10, 2022 Common Stock 329K $7.94 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units awards ("RSUs").
F2 The RSUs vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F3 Shares underlying the options vest over a period of two years, in a series of eight successive equal installments from the date of the award, subject to the Reporting Person providing continuous service to the Issuer as of each such date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney